Mineralys Therapeutics Inc (MLYS)

Cost of Revenue

$21.00K

TTM · Period ending: · USD

MLYS logo

MLYS Cost of Revenue

Latest reported$21.00K
MLYS TTM Cost of Revenue ($0.00 → $21.00K)
High-resolution chart · PNG

MLYS cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Mineralys Therapeutics Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
21,000
21,000
15,000
15,000
0
0
8,000
8,000
8,000
8,000
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.